Showing 2,361 - 2,380 results of 21,342 for search '(( ((significant part) OR (significant factor)) decrease ) OR ( significant decrease decrease ))', query time: 0.60s Refine Results
  1. 2361
  2. 2362
  3. 2363
  4. 2364
  5. 2365
  6. 2366
  7. 2367
  8. 2368
  9. 2369

    IQGAP1 is a protein that plays a critical role in regulating the level of apoptosis in endothelial cells. by Shaojun Huang (12489901)

    Published 2025
    “…<p>(A) The Annexin V–FITC/propidium iodide (PI) assay results indicate that Si-IQGAP1 can slightly decrease the apoptosis rate of normal cells, whereas knocking down IQGAP1 in PA-induced cells (PA + Si-IQGAP1) can significantly reduce the apoptosis rate. …”
  10. 2370

    Abnormal expression of IQGAP1, cleaved caspase-3, BCL‐2, and BAX in the aortic wall of HFD mice and AS plaque. by Shaojun Huang (12489901)

    Published 2025
    “…(D) The TUNEL assay demonstrates significantly increased numbers of apoptotic cells in the aortas of HFD mice. …”
  11. 2371

    Inhibiting IQGAP1 expression restricts atherosclerotic plaque development. by Shaojun Huang (12489901)

    Published 2025
    “…(D) The TUNEL assay demonstrates that the number of apoptotic cells are significantly decreased in the AAV-Si-IQGAP1 group. (E,F) Western blot and densitometric analyses of each protein relative to β‐actin reveal decreased expression of IQGAP1, and pro-apoptotic proteins (cleaved caspase-3 and BAX), while YAP and the anti-apoptotic protein BCL-2 are increased in the aortic wall of the AAV-Si-IQGAP1 groups. …”
  12. 2372

    Changes in the neutrophil count. by Lu Yang (30847)

    Published 2025
    “…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
  13. 2373

    Changes in the platelet count. by Lu Yang (30847)

    Published 2025
    “…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
  14. 2374

    Changes in the white blood cell count. by Lu Yang (30847)

    Published 2025
    “…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
  15. 2375

    Changes in the hemoglobin. by Lu Yang (30847)

    Published 2025
    “…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
  16. 2376

    WBC and ANC on day 7 post-chemotherapy. by Lu Yang (30847)

    Published 2025
    “…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
  17. 2377

    General clinical data of 88 patients with NPC. by Lu Yang (30847)

    Published 2025
    “…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
  18. 2378

    CONSORT participant flow diagram. by Lu Yang (30847)

    Published 2025
    “…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
  19. 2379

    S4 File - by Lu Yang (30847)

    Published 2025
    “…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
  20. 2380